XOMA Revenue and Competitors

Location

$155.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • XOMA's estimated annual revenue is currently $75M per year.(i)
  • XOMA's estimated revenue per employee is $630,252
  • XOMA's total funding is $155.8M.

Employee Data

  • XOMA has 119 Employees.(i)
  • XOMA grew their employee count by 2% last year.

XOMA's People

NameTitleEmail/Phone
1
VP, Corporate ControllerReveal Email/Phone
2
Chief Investment OfficerReveal Email/Phone
3
Director Corporate DevelopmentReveal Email/Phone
4
Senior Accounting ManagerReveal Email/Phone
5
Senior AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is XOMA?

XOMA develops biopharmaceuticals that target cancer, immunological disorders and infectious diseases while leveraging its development and manufacturing infrastructure through partnerships with other pharmaceutical companies.

keywords:N/A

$155.8M

Total Funding

119

Number of Employees

$75M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

XOMA News

2022-04-17 - XOMA (NASDAQ:XOMA) Downgraded to Hold at StockNews ...

Several other research analysts also recently commented on XOMA. TheStreet raised shares of XOMA from a “c-” rating to a “b-” rating in a report...

2022-04-13 - XOMA Co. (NASDAQ:XOMA) Short Interest Update

Get XOMA alerts: Institutional investors and hedge funds have recently bought and sold shares of the stock. Geneos Wealth Management Inc.

2022-04-06 - XOMA : 2022 Letter to Stockholders

XOMA's milestone and royalty aggregator business model began to demonstrate its potential in 2021 and the first few months of 2022. There are...

2021-04-07 - XOMA CORPORATION XOMA Prices $35 Million Offering of Depositary Shares

EMERYVILLE, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the pricing of its underwritten registered public offering of 1,400,000 depositary shares at an initial public offering price of $25.00 per depositary share, raising g ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.9M1196%N/A
#2
$35M1194%N/A
#3
$25M119-4%N/A
#4
$34.5M1193%N/A
#5
$25.2M12012%N/A